Hiroshi Kamma

Summary

Affiliation: Kyorin University
Country: Japan

Publications

  1. ncbi Two cases of breast carcinoma with osteoclastic giant cells: are the osteoclastic giant cells pro-tumoural differentiation of macrophages?
    Yukiko Shishido-Hara
    Department of Pathology, Kyorin University School of Medicine 6 20 2, Shinkawa, Mitaka, Tokyo 181 8611, Japan
    Diagn Pathol 5:55. 2010
  2. ncbi Cyclic AMP-mediated growth suppression and MAPK phosphorylation in thyroid papillary carcinoma cells
    Hirofumi Matsumoto
    Department of Pathology, Kyorin University School of Medicine, Tokyo 181 8611, Japan
    Mol Med Report 1:245-9. 2008
  3. ncbi ATP-binding cassette transporters in primary central nervous system lymphoma: decreased expression of MDR1 P-glycoprotein and breast cancer resistance protein in tumor capillary endothelial cells
    Seiji Sakata
    Department of Pathology, Kyorin University Faculty of Medicine, 6 20 2 Shinkawa, Mitaka, Tokyo 181 8611, Japan
    Oncol Rep 25:333-9. 2011
  4. ncbi Alternative lengthening of telomeres in the human adrenocortical carcinoma cell line H295R
    Masachika Fujiwara
    Department of Pathology, Kensei General Hospital, Iwase, Nishi-Ibaraki, Ibaraki 309-1295, Japan
    Int J Oncol 29:445-51. 2006
  5. ncbi Decreased expression of the thyroid-stimulating hormone receptor in poorly-differentiated carcinoma of the thyroid
    Hirofumi Matsumoto
    Department of Pathology, Kyorin University School of Medicine, Tokyo, Japan
    Oncol Rep 19:1405-11. 2008
  6. ncbi Expression of stem cell factor (SCF), a KIT ligand, in gastrointestinal stromal tumors (GISTs): a potential marker for tumor proliferation
    Kazuhiko Hirano
    Department of Pathology, Kyorin University School of Medicine, Mitaka, Tokyo, Japan
    Pathol Res Pract 204:799-807. 2008
  7. ncbi Divergent expression of L-type amino acid transporter 1 during uterine cervical carcinogenesis
    Kaname Uno
    Kyorin University School of Medicine, Tokyo 181 8611, Japan
    Hum Pathol 42:1660-6. 2011
  8. ncbi Histiocytoid breast carcinoma: solid variant of invasive lobular carcinoma with decreased expression of both E-cadherin and CD44 epithelial variant
    Masachika Fujiwara
    Department of Pathology, Kensei General Hospital, Iwase, Nishi-Ibaraki, Japan
    Pathol Int 55:353-9. 2005

Collaborators

Detail Information

Publications8

  1. ncbi Two cases of breast carcinoma with osteoclastic giant cells: are the osteoclastic giant cells pro-tumoural differentiation of macrophages?
    Yukiko Shishido-Hara
    Department of Pathology, Kyorin University School of Medicine 6 20 2, Shinkawa, Mitaka, Tokyo 181 8611, Japan
    Diagn Pathol 5:55. 2010
    ..Appearance of OGCs may not be anti-tumoural immunological reactions, but rather pro-tumoural differentiation of macrophage responding to hypervascular microenvironments induced by breast cancer...
  2. ncbi Cyclic AMP-mediated growth suppression and MAPK phosphorylation in thyroid papillary carcinoma cells
    Hirofumi Matsumoto
    Department of Pathology, Kyorin University School of Medicine, Tokyo 181 8611, Japan
    Mol Med Report 1:245-9. 2008
    ..There could, however, be other mechanisms by which cAMP signaling inhibits the growth of papillary carcinoma cells...
  3. ncbi ATP-binding cassette transporters in primary central nervous system lymphoma: decreased expression of MDR1 P-glycoprotein and breast cancer resistance protein in tumor capillary endothelial cells
    Seiji Sakata
    Department of Pathology, Kyorin University Faculty of Medicine, 6 20 2 Shinkawa, Mitaka, Tokyo 181 8611, Japan
    Oncol Rep 25:333-9. 2011
    ..Thus, decreased expression may permit delivery of chemotherapeutic agents to the tumor tissues...
  4. ncbi Alternative lengthening of telomeres in the human adrenocortical carcinoma cell line H295R
    Masachika Fujiwara
    Department of Pathology, Kensei General Hospital, Iwase, Nishi-Ibaraki, Ibaraki 309-1295, Japan
    Int J Oncol 29:445-51. 2006
    ..We anticipate that H295R cells will be a good model for understanding the significance and mechanism of ALT in human cancers...
  5. ncbi Decreased expression of the thyroid-stimulating hormone receptor in poorly-differentiated carcinoma of the thyroid
    Hirofumi Matsumoto
    Department of Pathology, Kyorin University School of Medicine, Tokyo, Japan
    Oncol Rep 19:1405-11. 2008
    ..In conclusion, we demonstrated that TSHR expression was decreased in PDCs despite conserved TTF-1 expression and that it correlated to the proliferative activity in PDCs...
  6. ncbi Expression of stem cell factor (SCF), a KIT ligand, in gastrointestinal stromal tumors (GISTs): a potential marker for tumor proliferation
    Kazuhiko Hirano
    Department of Pathology, Kyorin University School of Medicine, Mitaka, Tokyo, Japan
    Pathol Res Pract 204:799-807. 2008
    ..Thus, SCF expression would be a useful marker for tumor proliferation...
  7. ncbi Divergent expression of L-type amino acid transporter 1 during uterine cervical carcinogenesis
    Kaname Uno
    Kyorin University School of Medicine, Tokyo 181 8611, Japan
    Hum Pathol 42:1660-6. 2011
    ....
  8. ncbi Histiocytoid breast carcinoma: solid variant of invasive lobular carcinoma with decreased expression of both E-cadherin and CD44 epithelial variant
    Masachika Fujiwara
    Department of Pathology, Kensei General Hospital, Iwase, Nishi-Ibaraki, Japan
    Pathol Int 55:353-9. 2005
    ..Decreased expression of both E-cadherin and CD44 epithelial variant may be responsible for the loose cellular cohesiveness observed in HBC...